AVM
KRTX

Arch Venture Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Arch Venture Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,000
Closed -$5.45M – 8
2023
Q1 		$5.45M Sell
30,000
-482,872
-94% -$92.3M 2.63% 5
2022
Q4 		$101M Sell
512,872
-800,000
-61% -$172M 25.81% 2
2022
Q3 		$295M Sell
1,312,872
-1,600,000
-55% -$324M 38.28% 1
2022
Q2 		$369M Hold
2,912,872
– – 44.91% 1
2022
Q1 		$369M Hold
2,912,872
– – 52.78% 1
2021
Q4 		$382M Buy
+2,912,872
New +$376M 40.37% 1

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return